For the first time, researchers at Fred Hutchinson Cancer Research Center have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat a group of leukemia and pre-leukemia patients for whom there previously had been no other curative treatment options.

Read the original:
Advanced Leukemia Successfully Treated With First Use Of Antibody And Stem Cell Transplantation

Related posts:

1. Autologous Stem Cell Transplantation For Soft Tissue Sarcoma: Insufficient Research Into TherapyDue to a lack of suitable studies, it is unclear whether patients with soft tissue sarcoma can benefit from autologous haematopoietic stem cell transplantation. With this type of therapy, some...
2. Advanced Cell Technology Files IND With FDA For First Human Clinical Trial Using Embryonic Stem Cells To Treat Eye DiseaseAdvanced Cell Technology, Inc. (OTCBB:ACTC) announced that it filed an Investigational New Drug (IND) Application with the US Food and Drug Administration (FDA) to initiate a Phase I/II multicenter study...
3. LFB’s Recombinant Anti-CD20 Monoclonal Antibody Is Granted Orphan Drug Status In Europe For Chronic Lymphocytic LeukemiaThe recombinant anti-CD20 monoclonal antibody produced by LFB Biotechnologies received orphan drug status for the treatment of Chronic Lymphocytic Leukemia (CLL). This approval from the EMEA's Committee for Orphan Medicinal...
4. Transplantation Of Stem Cells Alleviates Side Effects Of Radiotherapy In RatsHuman embryonic stem cells could help people with learning and memory deficits after radiation treatment for brain tumors, suggests a new UC Irvine study. Research with rats found that transplanted...
5. Celldex Therapeutics Presents Positive Results From Phase 2 Study Of The Antibody-Drug Conjugate Product Candidate CDX-011 In Advanced Breast CancerCelldex Therapeutics, Inc. (NASDAQ: CLDX) announced the results of a positive Phase 2 study of CDX-011 (formerly CR011-vcMMAE), in patients with heavily pre-treated, locally advanced or metastatic breast cancers. As...
6. Islet Cell Transplantation In ScotlandThe Scottish National Blood Transfusion Service has opened a new laboratory in Edinburgh to offer around 12 people a year islet cell transplant therapy. Islet cell transplant therapy is a...
7. Cholesterol-Lowering Drugs Also May Protect Stem Cell Transplant Patients From A Potentially Deadly ComplicationCholesterol-lowering drugs known as statins are among the most prescribed medicines in the U.S. Now a new study by researchers at Fred Hutchinson Cancer Research Center indicates that statins may...
8. New Ethical Questions Are Being Raised In Stem Cell ResearchA groundbreaking discovery two years ago that turned ordinary skin cells back into an embryonic or "pluripotent" state was hailed as the solution to the controversial ethical question that has...
9. Arno Therapeutics Announces Poster Presentation At ASH Annual Meeting Demonstrating Anti-Leukemic Stem Cell Activity Of AR-42Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on oncology therapeutics, today announced the presentation of a poster at the annual American Society of Hematology (ASH) meeting that describes the...
10. StemCells, Inc. Welcomes Approval Of First Embryonic Stem Cell Lines Under New NIH GuidelinesStemCells, Inc. (NASDAQ: STEM) announced that it welcomes the approval yesterday by the National Institutes of Health (NIH) of the first 13 human embryonic stem cell (hESC) lines for use...
11. Hebrew University, American Researchers Show Genetic ‘trigger’ To Stem Cell DifferentiationA gene which is essential for stem cells' capabilities to become any cell type has been identified by researchers at the Hebrew University of Jerusalem and the University of California,...
12. The Indefinite Self Renewal Of Specialized Cells Without The Need For Stem Cell IntermediatesIs the indefinite expansion of adult cells possible without recourse to stem cell intermediates? The team led by Michael Sieweke at the Centre d'immunologie de Marseille Luminy (Université Aix-Marseille 2...
13. New Stem Cell Technology Developed At Hebrew University – Leads To Better Treatment For Complicated Bone FracturesA novel technology involving use of stem cells, developed by Hebrew University of Jerusalem researchers, has been applied to provide better and rapid healing for patients suffering from complicated bone...
14. Univ. Of Nebraska Board Of Regents Votes To Maintain Current Embryonic Stem Cell PolicyThe University of Nebraska Board of Regents last week voted 4-4 not to restrict embryonic stem cell research policy beyond current federal and state limits, the New York Times reports....
15. $11 Million NIH Grant For Stem Cell Research Awarded To Rhode Island HospitalRhode Island Hospital has received an $11 million grant to fund research that will lead to a general understanding of stem cell biology and identify unique approaches to tissue regeneration...